Dynavax Technologies (DVAX) Q2 Earnings and Revenues Top EstimatesZacks Investment Research • 08/04/21
Dynavax Technologies (DVAX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 07/28/21
Dynavax to Report Second Quarter 2021 Financial Results and Host Conference Call on August 4, 2021PRNewsWire • 07/21/21
Dynavax and Biological E Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Biological E's COVID-19 Vaccine CandidatePRNewsWire • 07/06/21
Clover and Dynavax Announce Commercial Supply Agreement of Dynavax's CpG 1018 Adjuvant for Clover's COVID-19 Vaccine CandidatePRNewsWire • 06/30/21
Dynavax to Present at the Goldman Sachs 42nd Annual Global Healthcare ConferencePRNewsWire • 06/09/21
Valneva Completes Phase 3 Trial Recruitment for its Inactivated COVID-19 Vaccine CandidateGlobeNewsWire • 06/03/21
Dynavax Announces Agreement with Bavarian Nordic for Commercialization of HEPLISAV B®, a Two Dose Adult Hepatitis B Adjuvanted Vaccine, in GermanyPRNewsWire • 05/27/21
Bavarian Nordic Announces Marketing and Distribution Agreement with Dynavax to Launch HEPLISAV B® Hepatitis B Vaccine in GermanyGlobeNewsWire • 05/27/21
Valneva to Participate in the World's First COVID-19 Vaccine Booster Trial in the UKGlobeNewsWire • 05/19/21
Dynavax: A Strong 2021 Plus Market Tailwinds Makes This Discounted Stock AttractiveSeeking Alpha • 05/13/21